Showing posts with label option. Show all posts
Showing posts with label option. Show all posts
Saturday, May 22, 2010
Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
CONCLUSION:
Secondary cytoreduction in relapsed ovarian cancer is safe and feasible and perioperative outcome is not inferior compared to primary cytoreduction. Surgery-associated morbidity should represent a minor aspect in the selection and counselling of patients regarding treatment options for recurrent ovarian cancer.
add your opinions
breast conserving surgery
,
morbidity
,
option
,
patient safety
,
second cytoreductive surgery
,
secondary
Subscribe to:
Posts
(
Atom
)